Ligand validation:4XTI

IMP: INOSINIC ACID

IMP is a Ligand Of Interest in 4XTI designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
4XTI_IMP_B_601	81%	47%	0.106	0.957	0.97	1.06	1	2	1	0	100%	1
4XTI_IMP_A_601	72%	47%	0.109	0.933	0.98	1.06	2	3	1	0	100%	0.913
4XTD_IMP_A_601	69%	13%	0.136	0.952	2.75	1.3	7	4	1	0	100%	0.6565
8QWA_IMP_A_501	100%	47%	0.038	0.987	1.01	1.04	3	3	0	0	100%	1
9C4M_IMP_G_801	99%	55%	0.051	0.982	0.94	0.79	1	-	0	0	100%	1
4FXS_IMP_A_701	98%	17%	0.056	0.98	1.71	1.89	4	7	1	0	100%	1
5UWX_IMP_C_501	98%	33%	0.06	0.984	1.3	1.35	3	2	2	0	100%	1
2C6Q_IMP_E_1337	98%	19%	0.06	0.984	1.94	1.53	5	6	3	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.